CD4 and neoplasm: Early mechanistic studies also demonstrated that CD40 stimulation can enhance the efficacy of tumor antigen vaccination (144, 145), induce activation of endogenous CD4+ T cells (144) and reverse cytotoxic T cell tolerance (145).